All In MedTech

PMA device

Axonics Sacral Neuromodulation System

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

22

PMA pathway

Device trials

5

Naming "Axonics Sacral Neuromodulation"

MAUDE reports

11

Brand "Axonics Sacral Neuromodulation", since 2015

PubMed studies

0

Mentioning "Axonics Sacral Neuromodulation"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Axonics Sacral Neuromodulation System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology, with pictures of the device
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 6 of 22 decisions filed under this name.

5 more FDA decisions with a free account

Older decisions: P190006-S079, P190006-S078, P190006-S076, P190006-S071, P190006-S066, P190006-S063, P190006-S062, P190006-S061, P190006-S056, P190006-S054, P190006-S038, P190006-S025, P190006-S024, P190006-S015, P190006-S011, P190006

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "Axonics Sacral Neuromodulation", any status and sponsor, newest update first.

Open in Trial Radar
  • Axonics, Inc.Not on our public-company list

    NCT07335484 · 75 participants (planned) · Start Apr 30, 2026 · Primary completion Nov 2026

    Device: Axonics External Trial System (ETS) · For: Urinary Urge Incontinence (UUI); Urinary Frequency (UF); Fecal Incontinence (FI) and 1 more

    Sites: Birmingham, Alabama; Macon, Georgia; Chicago, Illinois · 6 sites in all

4 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Axonics Sacral Neuromodulation", and for the whole product code for context.

This brand

11 reports: 3 malfunction, 5 injury, 0 death

Whole product code QON

10 reports: 3 malfunction, 7 injury, 0 death

Newest reports for this brand

4 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "Axonics Sacral Neuromodulation"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code QON.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.